CGC exploded from about $8.50 to a high of $14.92
CGC exploded from about $8.50 to a high of $14.92
You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here. Prefer to view this content on our website? Click here.
Dear Fellow Investor,
On April 29, we noted, "Keep an eye on cannabis stocks as we near the election. investors may want to consider related stocks, such as Canopy Growth (CGC) and ETFs such as the Advisor Shares Pure US Cannabis ETF (MSOS)."
Since then, CGC exploded from about $8.50 to a high of $14.92.
MSOS ran from about $8.40 to a high of $11.36.
Both could race even higher after the US DEA said it will reclassify cannabis as a less dangerous drug. As noted by the Associated Press, "Once OMB [White House Office of Management and Budget] signs off, the DEA will take public comment on the plan to move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD. It moves pot to Schedule III, alongside ketamine and some anabolic steroids."
This is historic news that could have a substantial impact on the cannabis story.
Sponsored
Potential Drug Delivery Breakthrough
Up to 40% of people have difficulty swallowing pills. IntelGenx is working to change that. Led by the co-inventor of the Listerine strip, the company applies similar oral film technology to pharma, making ingestion easier and enhancing medicine absorption.
This isn't just a convenient alternative; it's a potential game-changer in how medicine is taken. Invest in IntelGenx now and be part of a company working to revolutionize a variety of treatments, making vital medications accessible and more effective for everyone.
Learn more.
A growing number of Americans want to see it legalized. In fact, according to Pew Research, about 88% of Americans want to see that happen.
"An overwhelming majority of U.S. adults (88%) say either that marijuana should be legal for medical use only (32%) or that it should be legal for medical and recreational use (57%). Just 11% say the drug should not be legal in any form. These views have held relatively steady over the past five years," reported Pew Research.
Sponsored
This "AI parallel" stock is expected to grow 12,300% by 2030
Just $5,000 could turn into a $620,000 windfall.
Full Details Here
Even an upcoming vote on adult-use in Florida has been fueling upside. According to MJBizDaily.com, "Florida is poised to become the next state to legalize adult-use marijuana. The state's Supreme Court ruled Monday that an industry-funded ballot initiative will appear on state voters' November ballots." All could help send related cannabis stocks to higher highs.
Sponsored
7 Cheap & Good Stocks to Buy in May!
It's the holy grail of the stock market...
Stocks that trade for pennies on the dollar yet have the potential to skyrocket for monster gains.
Our partners at Trading Tips have uncovered SEVEN such stocks.
And ALL of them trade for ultra cheap right now.
Simply follow this link and claim your copy today at no charge whatsoever.
(By clicking this link you agree to receive emails from us and our affiliates. You can opt out at any time.)
|
Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431
Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.
Behind the Markets
Unsubscribeinvisiblelink
|
|
Tidak ada komentar:
Posting Komentar